The chemical industry has gone to Congress over delays in U.S. Environmental Protection Agency reviews, asking lawmakers to intervene where the agency's own timelines have slipped.

The appeal, reported by EP Magazine, marks a shift in venue for a sector that has previously pressed its case through EPA's administrative channels. The industry's core argument is procedural: EPA review processes are taking longer than the statutory and business planning timelines that chemical manufacturers work against, and Congress — not the agency alone — holds the tools to correct that.

Why are chemical manufacturers appealing to Congress?

Chemical production sits at the base of multiple material streams that recycling and circular-economy systems depend on — polymers, solvents, intermediates and the process chemistry behind mechanical and advanced recycling alike. When EPA reviews of new or existing chemical substances stall, downstream projects that rely on those substances inherit the delay.

For the recycling sector, that transmission matters. A pending feedstock approval or a stalled risk evaluation can hold up:

• commissioning schedules for chemical recycling facilities awaiting determinations on feedstock or output classifications;
• investment decisions tied to substances under EPA review;
• compliance planning for sites handling chemicals still awaiting finalized determinations.

The industry's turn to Congress signals that administrative engagement has not resolved the bottleneck to its satisfaction.

What does the industry want changed?

According to the report, the sector wants congressional action directed at the pace of EPA's review processes — not a rollback of the underlying environmental statutes. That framing is deliberate. Chemical manufacturers have argued for years that slow reviews impose real costs without producing proportionate environmental benefit, since the delay itself does not change the eventual regulatory outcome.

The ask lands on Capitol Hill at a moment when permitting reform has bipartisan traction in principle, even as the specifics remain contested. Chemical industry lobbying has increasingly framed EPA review timelines as a competitiveness issue, positioning administrative throughput — not stringency — as the point of contention.

Who carries the burden of the delays?

For facility operators and project developers, the practical consequence is schedule risk. Chemical and recycling projects are typically financed against dated milestones: permit decisions, substance determinations, and compliance deadlines feed directly into construction and commissioning plans. A review that runs long pushes every downstream milestone with it.

The industry's position is that Congress can impose structure — deadlines, resource allocation, or procedural requirements — that the agency has not delivered on its own. Opponents of such measures typically counter that review timelines reflect workload and statutory scope, and that legislating speed risks cutting analysis short.

What happens next?

The immediate milestone is congressional. Whether the chemical industry's appeal translates into legislation, oversight hearings, or budget direction to EPA will determine whether review timelines actually move. EP Magazine's report identifies the ask; the tracking point for the recycling and chemicals trades is any bill text, committee hearing or appropriation rider that would attach enforceable timelines to EPA's review processes.

Until one of those vehicles advances, the delays the industry describes remain an operating condition that chemical producers — and the recycling projects downstream of them — will keep pricing into their schedules.